Potential Indications of Modulators of the Endocannabinoid System
{"Image DocumentName": "Potential Indications of Modulators of the Endocannabinoid System", "Image ImageDescription": "Cb1-Antagonists (Rimonabant and Successors): Smoking Cessation. Cb2-Agonists: Osteoporosis. Anandamide Breakdown Inhibitors (FAAH Inhibitors) Epilepsy. Parkinson\u2018s Disease. Alzheimer\u2018s Disease. Nociceptive Pain. Stress-induced pain: Anxiety, posttraumatic stress disorder. Learning \u2013 Extinction. Inflammatory Conditions: Multiple Sclerosis, IBD? Tumor cell proliferation. Johannes Klein. Department of Internal Medicine I.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}